Our clinical trials network
The North American Clinical Trials Network (NACTN) works to bring promising therapies out of the laboratory and into clinical trials, in a manner that provides strong evidence of effectiveness and safety.

Learn how NACTN works to evaluate the safety and effectiveness of potential treatments for spinal cord injury.

There are 10 NACTN clinical centers in North America with additional sites for data management and pharmacology.

The NACTN SCI Registry tracks acute care and follow-up data on patients following a spinal cord injury.

Common questions, and a look at some of the current clinical trials that are exploring new frontiers in the field.

It is important for patients to educate themselves and ask questions before volunteering to join a clinical trial.

Review highlights from the Journal of Neurosurgery Focus Issue on spinal cord injury, September 2012, v17.

RISCIS is a study supported by NACTN and AOSpine North America to evaluate the safety of riluzole in treating SCI.